Upacicalcet

Upacicalcet is a drug used to treat secondary hyperparathyroidism (SHPT) - a disease of the parathyroid gland - in dialysis patients. It was approved as Upasita in Japan in June 2021. The drug is given intravenously. The active ingredient is used in the form of its sodium salt.
Wikipedia contributors, "Upacicalcet", Wikipedia, revision 1329897269, retrieved 20 November 2026, source, CC BY-SA 4.0.